Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing. 1998

M A Pfaller, and S Arikan, and M Lozano-Chiu, and Y Chen, and S Coffman, and S A Messer, and R Rennie, and C Sand, and T Heffner, and J H Rex, and J Wang, and N Yamane
Department of Pathology, University of Iowa, Iowa City, Iowa 52242, USA. mpfaller@blue.weeg.uiowa.edu

A method using a commercially prepared colorimetric microdilution panel (ASTY; Kyokuto Pharmaceutical Industrial Co., Ltd.) was compared in four different laboratories with the National Committee for Clinical Laboratory Standards (NCCLS) reference microdilution method by testing 802 clinical isolates of Candida spp. (C. albicans, C. glabrata, C. tropicalis, C. parapsilosis, C. krusei, C. lusitaniae, C. guilliermondii, C. lipolytica, C. rugosa, and C. zeylanoides) against amphotericin B, 5-fluorocytosine (5FC), fluconazole, and itraconazole. Reference MIC endpoints were established after 48 h of incubation, and ASTY endpoints were established after 24 and 48 h of incubation. ASTY endpoints were determined to be the time at which the color of the first well changed from red (indicating growth) to purple (indicating growth inhibition) or blue (indicating no growth). Excellent agreement (within 2 dilutions) between the reference and colorimetric MICs was observed. Overall agreement was 93% at 24 h and 96% at 48 h. Agreement ranged from 90% with itraconazole and 5FC to 96% with amphotericin B at 24 h and from 92% with itraconazole to 99% with amphotericin B and 5FC at 48 h. The ASTY colorimetric microdilution panel method appears to be comparable to the NCCLS reference method for testing the susceptibilities of Candida spp. to a variety of antifungal agents.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D007753 Laboratories Facilities equipped to carry out investigative procedures. Laboratory
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011786 Quality Control A system for verifying and maintaining a desired level of quality in a product or process by careful planning, use of proper equipment, continued inspection, and corrective action as required. (Random House Unabridged Dictionary, 2d ed) Control, Quality,Controls, Quality,Quality Controls
D002175 Candida A genus of yeast-like mitosporic Saccharomycetales fungi characterized by producing yeast cells, mycelia, pseudomycelia, and blastophores. It is commonly part of the normal flora of the skin, mouth, intestinal tract, and vagina, but can cause a variety of infections, including CANDIDIASIS; ONYCHOMYCOSIS; VULVOVAGINAL CANDIDIASIS; and CANDIDIASIS, ORAL (THRUSH). Candida guilliermondii var. nitratophila,Candida utilis,Cyberlindnera jadinii,Hansenula jadinii,Lindnera jadinii,Monilia,Pichia jadinii,Saccharomyces jadinii,Torula utilis,Torulopsis utilis,Monilias
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002177 Candidiasis Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed) Candida Infection,Moniliasis,Candida Infections,Candidiases,Infection, Candida,Moniliases
D003124 Colorimetry Any technique by which an unknown color is evaluated in terms of standard colors. The technique may be visual, photoelectric, or indirect by means of spectrophotometry. It is used in chemistry and physics. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
D005437 Flucytosine A fluorinated cytosine analog that is used as an antifungal agent. 5-Fluorocytosine,Alcobon,Ancobon,Ancotil
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M A Pfaller, and S Arikan, and M Lozano-Chiu, and Y Chen, and S Coffman, and S A Messer, and R Rennie, and C Sand, and T Heffner, and J H Rex, and J Wang, and N Yamane
January 1996, Rinsho byori. The Japanese journal of clinical pathology,
M A Pfaller, and S Arikan, and M Lozano-Chiu, and Y Chen, and S Coffman, and S A Messer, and R Rennie, and C Sand, and T Heffner, and J H Rex, and J Wang, and N Yamane
July 2002, Journal of clinical microbiology,
M A Pfaller, and S Arikan, and M Lozano-Chiu, and Y Chen, and S Coffman, and S A Messer, and R Rennie, and C Sand, and T Heffner, and J H Rex, and J Wang, and N Yamane
June 1996, Diagnostic microbiology and infectious disease,
M A Pfaller, and S Arikan, and M Lozano-Chiu, and Y Chen, and S Coffman, and S A Messer, and R Rennie, and C Sand, and T Heffner, and J H Rex, and J Wang, and N Yamane
February 1997, Rinsho byori. The Japanese journal of clinical pathology,
M A Pfaller, and S Arikan, and M Lozano-Chiu, and Y Chen, and S Coffman, and S A Messer, and R Rennie, and C Sand, and T Heffner, and J H Rex, and J Wang, and N Yamane
March 2002, Chemotherapy,
M A Pfaller, and S Arikan, and M Lozano-Chiu, and Y Chen, and S Coffman, and S A Messer, and R Rennie, and C Sand, and T Heffner, and J H Rex, and J Wang, and N Yamane
August 1994, Journal of clinical microbiology,
M A Pfaller, and S Arikan, and M Lozano-Chiu, and Y Chen, and S Coffman, and S A Messer, and R Rennie, and C Sand, and T Heffner, and J H Rex, and J Wang, and N Yamane
July 2008, Journal of clinical microbiology,
M A Pfaller, and S Arikan, and M Lozano-Chiu, and Y Chen, and S Coffman, and S A Messer, and R Rennie, and C Sand, and T Heffner, and J H Rex, and J Wang, and N Yamane
October 1995, Journal of clinical microbiology,
M A Pfaller, and S Arikan, and M Lozano-Chiu, and Y Chen, and S Coffman, and S A Messer, and R Rennie, and C Sand, and T Heffner, and J H Rex, and J Wang, and N Yamane
January 2008, Chemotherapy,
M A Pfaller, and S Arikan, and M Lozano-Chiu, and Y Chen, and S Coffman, and S A Messer, and R Rennie, and C Sand, and T Heffner, and J H Rex, and J Wang, and N Yamane
July 1994, Journal of clinical microbiology,
Copied contents to your clipboard!